FHIR Release 3 (STU) R4 Ballot #1 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.0.2: STU 3). (v3.3.0: R4 Ballot 2). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationadministration0310

Pharmacy Work Group Maturity Level : N/A Ballot Status : Informative Compartments : Device , Encounter , Patient , Practitioner , RelatedPerson

This is the narrative for the resource. See also the XML or JSON format. This example conforms to the profile MedicationAdministration .

Generated Narrative with Details

id : medadmin0310

contained :

status : completed

medication : id: med0304; Myleran 2mg tablet, film coated (Details : {http://hl7.org/fhir/sid/ndc code '76388-713-25' = '76388-713-25', given as 'Myleran 2mg tablet, film coated'})

subject : Donald Duck

effective : 15/01/2015 10:03:00 PM --> 16/01/2015 2:03:00 AM

Performers

- Actor
* Patrick Pump

prescription request : MedicationRequest/medrx0306

Dosages

- Text Route Dose
* 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL Oral route (qualifier value) (Details : {SNOMED CT code '26643006' = 'Oral route', given as 'Oral route (qualifier value)'}) 6 mg (Details: UCUM code mg = 'mg')

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.